These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11359763)

  • 41. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
    Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
    J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of Anti-Ischemic and Cardioprotective Effects of Nicorandil in Patients With Stable Angina].
    Rezvanova YA; Adamchik AS
    Kardiologiia; 2015; 55(8):21-5. PubMed ID: 26761967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nicorandil decreases cardiac events during and after noncardiac surgery.
    Kashimoto S; Seki M; Ishiguro T; Yoshioka H; Nagata O; Nishimura K; Kikuchi T; Yamada T; Iwade M; Omi A; Honda O; Sakamoto A; Ogihara Y; Fujimoto K; Nakaigawa Y; Kato J; Watanabe A; Nomura M; Takeda J
    J Clin Anesth; 2007 Feb; 19(1):44-8. PubMed ID: 17321926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the outcomes of the prolonged antianginal therapy use in stable coronary artery disease patients according to the data of randomized and observational studies.
    Martsevich SY; Lukina YV; Kutishenko NP; Semenova YV
    Contemp Clin Trials Commun; 2021 Mar; 21():100743. PubMed ID: 33665472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
    Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
    Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral nicorandil reduces ischemic attacks in patients with stable angina: A prospective, multicenter, open-label, randomized, controlled study.
    Jiang J; Li Y; Zhou Y; Li X; Li H; Tang B; Dai X; Ma T; Li L; Huo Y
    Int J Cardiol; 2016 Dec; 224():183-187. PubMed ID: 27657471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study.
    Horinaka S; Yabe A; Yagi H; Ishimitsu T; Yamazaki T; Suzuki S; Kohro T; Nagai R;
    Circ J; 2010 Mar; 74(3):503-9. PubMed ID: 20081320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
    Araki H; Hayata N; Matsuguchi T; Nakamura M
    Clin Ther; 1987; 9(2):174-82. PubMed ID: 2952276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased cardiac mortality with nicorandil in patients with ischemic heart failure.
    Yoshihisa A; Sato Y; Watanabe S; Yokokawa T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Takeishi Y
    BMC Cardiovasc Disord; 2017 May; 17(1):141. PubMed ID: 28569214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and prognostic implications of stable angina pectoris among women and men.
    Hemingway H; McCallum A; Shipley M; Manderbacka K; Martikainen P; Keskimäki I
    JAMA; 2006 Mar; 295(12):1404-11. PubMed ID: 16551712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

  • 52. Nicorandil-induced severe perianal ulceration.
    Baker RP; Al-Kubati W; Atuf M; Phillips RK
    Tech Coloproctol; 2007 Dec; 11(4):343-5. PubMed ID: 18060591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicorandil for angina.
    Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of different nitrate therapies on long-term clinical outcomes of patients with vasospastic angina: A propensity score-matched analysis.
    Kim CH; Park TK; Cho SW; Oh MS; Lee DH; Seong CS; Gwag HB; Lim AY; Yang JH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Ahn J; Carriere KC; Choi SH
    Int J Cardiol; 2018 Feb; 252():1-5. PubMed ID: 29249418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
    Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction.
    Sakata Y; Nakatani D; Shimizu M; Suna S; Usami M; Matsumoto S; Hara M; Sumitsuji S; Kawano S; Iwakura K; Hamasaki T; Sato H; Nanto S; Hori M; Komuro I
    J Cardiol; 2012 Jan; 59(1):14-21. PubMed ID: 21924584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Nicorandil and ulceration: a physiopathological hypothesis].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 Mar; 139(3):249-50. PubMed ID: 22401699
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of nicorandil on exercise performance in patients with effort angina: a multicenter trial using a treadmill exercise test.
    Kato K; Asanoi H; Wakabayashi C; Hosoda S; Shiina A; Hosono K; Kurita A; Seki K; Ishida K; Kuroiwa A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S98-103. PubMed ID: 2447432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effectiveness and safety of nicorandil in the treatment of patients with microvascular angina: A protocol for systematic review and meta-analysis.
    Zhang Y; Wang X; Liu R; Li Q; Tian W; Lei H; Shi C
    Medicine (Baltimore); 2021 Jan; 100(2):e23888. PubMed ID: 33466132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.